GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, ...

Research Triangle Park (RTP) is widely recognized as one of the foremost innovation hubs in the United States. Situated ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

On Oct. 26, 1944, after four days of furious fighting, the World War II battle of Leyte Gulf, largest air-naval clash in ...

There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical benefit of ...

The growth of the DEE treatment market can be attributed to the increasing prevalence of developmental and epileptic ...

The growth of the Chronic Hepatitis B Virus Testing market can be attributed to several key factors, including significant ...

Public health experts say they would “love” more answers about why a close contact of a Missouri avian flu patient had antibodies against the virus — but they’re relieved that the CDC found no ...

Global Cocaine Intoxication Treatment MarketThe global cocaine intoxication treatment market is projected to achieve a ...

Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...

UK pharmaceutical giant GlaxoSmithKline (GSK) has announced a five year collaboration with Cambridge University despite claims that a discontinued version of its heartburn drug causes cancer. GSK is ...